Thomas S. Lam

Thomas S. Lam, listed as chief executive, appears in our data through filings on Astrana Health, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 8 December 2017 to 6 October 2026, the count stands at 51 filings.

No open-market sale appears; the market trades are 8 purchases worth €702k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 21 share grants and 7 option exercises.

A typical purchase (the median) is worth €82k. On 7 out of 8 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. After 8 purchases with a full 90-day history, the hit rate stands at 75% and the median 90-day move at +2.5%. Past outcomes like these are no guarantee of what comes next.

Most recently, on 8 October 2026, the filings show a share grant worth €86k in Astrana Health, Inc. The latest purchase dates back some time: it was published 2,229 days ago, on 15 September 2020. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.